/
EHC
$100.48-$0.42 (-0.42%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$10.1B
99M shares
52-week range
$92.77 – $127.99
22% from low
Sector
SERVICES-HOSPITALS
Exchange
NYSE
CS
Borrow rate
0.27%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$20.72
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.28B | $4.61B | $3.57B | $4.01B | $4.35B | $4.80B | $5.37B | $5.94B |
| Cost of revenue | $158.7M | $167.9M | $171.0M | $2.31B | $2.60B | $2.82B | $3.14B | $254.4M |
| Gross profit | $4.12B | $4.44B | $3.40B | $1.70B | $1.75B | $1.98B | $2.23B | $5.68B |
| Gross margin | 96.3% | 96.4% | 95.2% | 42.4% | 40.3% | 41.3% | 41.6% | 95.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $681.6M | $692.5M | $0 | $659.4M | $630.2M | $1.72B | $864.5M | $1.05B |
| EBITDA | $840.2M | $940.7M | $739.6M | $888.9M | $870.1M | $1.01B | $1.19B | $1.40B |
| Net income | $292.3M | $358.7M | $284.2M | $412.2M | $271.0M | $352.0M | $455.7M | $566.2M |
| Net margin | 6.8% | 7.8% | 8.0% | 10.3% | 6.2% | 7.3% | 8.5% | 9.5% |
| EPS (diluted) | 2.93 | 3.61 | 2.85 | 4.11 | 2.70 | 3.47 | 4.46 | 5.54 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $6.4B | $6.01 | $5.78–$6.10 | 9 |
| 2027 | $6.9B | $6.54 | $6.23–$6.69 | 9 |
| 2028 | $7.5B | $7.28 | $6.78–$7.59 | 3 |
| 2029 | $8.2B | $8.37 | $8.33–$8.41 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$38.03
Price
$100.48
Implied downside
-62%
Peer comparison
Encompass Health Corporation Common Stock
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
www.encompasshealth.com- Employees
- 29,944
- IPO / List date
- Sep 13, 1989
- HQ
- BIRMINGHAM, AL
Held by traders on TradeandTell
No one on the platform currently holds EHC.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 265,000 | $25.6M |
| Bridgewater Associatesas of 2026-03-31 | 46,415 | $4.5M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 0.76% ($0.76/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-01 | $0.1900 | 2026-07-15 |
| 2026-04-01 | $0.1900 | 2026-04-15 |
| 2026-01-02 | $0.1900 | 2026-01-15 |
| 2025-10-01 | $0.1900 | 2025-10-15 |
| 2025-07-01 | $0.1700 | 2025-07-15 |
| 2025-04-01 | $0.1700 | 2025-04-15 |
| 2025-01-02 | $0.1700 | 2025-01-15 |
| 2024-10-01 | $0.1700 | 2024-10-15 |
| 2024-07-01 | $0.1500 | 2024-07-15 |
| 2024-03-28 | $0.1500 | 2024-04-15 |
Recent trades on TradeandTell
No one on the platform has traded EHC yet.
